![](https://webarchive.library.unt.edu/eot2008/20081004053554im_/http://www.fda.gov/graphics/dot_clear.gif) |
Topics on this Page
Introduction
The Food and Drug Administration has announced several new policies and procedures to strengthen its management of FDA advisory committees. They are detailed in four final guidance documents and one draft guidance. Our goal is to make our process for seeking advice from independent experts as open, public, and transparent as possible, so that we maintain the highest public confidence in that process.
New Guidance Documents
News Release
More on Advisory Committee Improvements
|
![](https://webarchive.library.unt.edu/eot2008/20081004053554im_/http://www.fda.gov/graphics/dot_clear.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081004053554im_/http://www.fda.gov/graphics/dot_clear.gif) |
|
![](https://webarchive.library.unt.edu/eot2008/20081004053554im_/http://www.fda.gov/graphics/dot_clear.gif) |
![](https://webarchive.library.unt.edu/eot2008/20081004053554im_/http://www.fda.gov/graphics/dot_clear.gif) |